Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology
Open Access
Abstract
Pax6 is a multifunctional transcription factor that orchestrates cell cycle progression at distinct stages of early embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways associated with pathological processes. Within this framework, Pax6 is regarded as an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The present review aims to examine published studies describing various Pax6-dependent molecular pathways to identify common principles and condition-specific differences in Pax6-regulated cascades in health and disease. These insights may contribute to the conceptual foundation for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data demonstrating a central role of Pax6 in governing the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.Keywords
All Related Versions
Funding Information
- Ministry of Health of Russian Federation (056-03-2025-071)
This publication has 235 references indexed in Scilit:
- PAX6, brain structure and function in human adults: advanced MRI in aniridiaAnnals of Clinical and Translational Neurology, 2016
- Transcriptional and epigenetic mechanisms of early cortical development: An examination of how Pax6 coordinates cortical developmentJournal of Comparative Neurology, 2015
- MiR‐135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF‐β/BMP signalingThe EMBO Journal, 2014
- Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitroGlia, 2011
- The role of Pax6 in forebrain developmentDevelopmental Neurobiology, 2011
- Lens morphogenesis is dependent on Pax6‐mediated inhibition of the canonical Wnt/beta‐catenin signaling in the lens surface ectodermGenesis, 2009
- Association of GSK3B With Alzheimer Disease and Frontotemporal DementiaArchives of Neurology, 2008
- Polymicrogyria and absence of pineal gland due to PAX6 mutationAnnals of Neurology, 2003
- Pax6; A pleiotropic player in developmentBioEssays, 2002
- Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell modelThe Prostate, 1996